NAD+ boosters: NMN & NR

Give this side its full due, because it is real. In randomized, placebo-controlled human trials, nicotinamide riboside reliably increases blood NAD+ in a dose-dependent way and is well tolerated.¹ Longer trials confirm the rise is sustained over weeks, with hints — not proof — of downstream effects like a small drop in blood pressure in one subgroup.² NMN shows the same core result: it raises NAD+ metabolites, and one trial in prediabetic women reported improved muscle insulin sensitivity, a biomarker outcome.⁴ So if your question is narrowly “does this pill raise the molecule it claims to?” the answer is yes. That already puts NAD+ boosters ahead of most of this shelf.

Here is the part the ads skip. Raising a biomarker is not the same as improving your health, and NAD+ is a textbook case of the difference. No human trial has shown that boosting NAD+ makes people age more slowly, think more clearly, recover faster or live longer. The studies are small (often dozens of people), short (weeks to a few months), and designed to measure blood chemistry, not real outcomes. The dramatic results — restored fur, better endurance, longer life — are almost all in mice. Betting that mouse lifespan data transfer to humans is exactly the bet resveratrol lost. Until a proper trial measures something that matters and finds it, the correct verdict is “plausible, unproven.”

NMN has a specifically awkward status in the United States. In 2022 the FDA concluded that because NMN had been authorized for investigation as a new drug, it is excluded from the legal definition of a dietary supplement — effectively telling sellers it should not be marketed as one.³ Enforcement has been patchy and products remain widely available, but the label “dietary supplement” on an NMN bottle is on shaky legal ground, and quality/purity vary a lot between brands. NR does not share this problem — it is an established, notified supplement ingredient — which is one practical reason people who want to try a NAD+ booster often choose NR.

Trial doses run roughly 250–1,000 mg/day for NR and a similar range for NMN. Both look safe and well tolerated over the months studied, with no serious signals; what we lack is long-term data. If you want to experiment with a marker you can even measure, that is a defensible personal choice — pick a reputable brand, prefer NR on the regulatory grounds above, and be clear-eyed that you are buying a raised number, not a proven benefit. What you should not do is treat it as established anti-aging medicine, spend heavily on it, or let it displace the things with real outcome evidence: exercise, protein, sleep.